SURF Surface Oncology, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

SURF [NASD]

Surface Oncology, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-0.89	Insider Own	16.76%	Shs Outstand	33.42M	Perf Week	-5.53%
Market Cap	356.49M	Forward P/E	-	EPS next Y	-1.62	Insider Trans	-10.12%	Shs Float	17.04M	Perf Month	37.83%
Income	-25.10M	PEG	-	EPS next Q	-0.39	Inst Own	69.40%	Short Float	3.33%	Perf Quarter	56.24%
Sales	39.40M	P/S	9.05	EPS this Y	-495.10%	Inst Trans	1.20%	Short Ratio	0.55	Perf Half Y	207.61%
Book/sh	2.92	P/B	3.04	EPS next Y	-134.80%	ROA	-18.00%	Target Price	10.80	Perf Year	548.91%
Cash/sh	2.81	P/C	3.17	EPS next 5Y	-	ROE	-32.90%	52W Range	1.31 - 10.25	Perf YTD	372.87%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-88.70%	52W High	-13.27%	Beta	-
Dividend %	-	Quick Ratio	11.10	Sales past 5Y	-	Gross Margin	-	52W Low	578.63%	ATR	0.89
Employees	49	Current Ratio	11.10	Sales Q/Q	-	Oper. Margin	-	RSI (14)	59.81	Volatility	13.42% 11.45%
Optionable	Yes	Debt/Eq	0.16	EPS Q/Q	30.50%	Profit Margin	-63.70%	Rel Volume	0.90	Prev Close	9.33
Shortable	Yes	LT Debt/Eq	0.16	Earnings	-	Payout	-	Avg Volume	1.03M	Price	8.89
Recom	1.60	SMA20	15.96%	SMA50	28.90%	SMA200	100.12%	Volume	936,104	Change	-4.72%

Sep-04-20

Initiated

H.C. Wainwright

Buy

$11

Aug-28-20

Initiated

Wedbush

Outperform

$12

Sep-19-18

Initiated

Robert W. Baird

Outperform

May-14-18

Initiated

Goldman

Neutral

$17

May-14-18

Initiated

Evercore ISI

Outperform

$26

Oct-20-20 01:03PM	Is Surface Oncology (NASDAQ:SURF) Using Too Much Debt? Simply Wall St. +10.94%
Oct-19-20 12:32PM	Zacks.com featured highlights include: Daqo, Surface Oncology, Covenant, Herc and Castle Biosciences Zacks -10.72%
Oct-12-20 03:41PM	Why Surface Oncology Stock Soared Today Motley Fool +32.07%
Sep-16-20 05:05PM	Surface Oncology to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit GlobeNewswire
Sep-15-20 07:23AM	Surface Oncology's Shares March Higher, Can It Continue? Zacks
Sep-11-20 03:00PM	Surface Oncology to Participate in the H.C. Wainwright Global Healthcare Conference GlobeNewswire
Sep-09-20 01:15PM	Surface Oncology to Present at the Baird Global Healthcare Conference GlobeNewswire
Sep-04-20 09:38AM	Benzinga's Top Upgrades, Downgrades For September 4, 2020 Benzinga -5.31%
Sep-02-20 08:52AM	Surface Oncology (SURF) Looks Good: Stock Adds 9.8% in Session Zacks
Aug-28-20 10:16AM	Benzinga's Top Upgrades, Downgrades For August 28, 2020 Benzinga +16.57%
Aug-19-20 01:56PM	What Type Of Shareholders Own The Most Number of Surface Oncology, Inc. (NASDAQ:SURF) Shares? Simply Wall St. +13.03%
Aug-11-20 06:30AM	Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2020 GlobeNewswire
Aug-05-20 11:59AM	Surface Oncology to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference GlobeNewswire +6.22%
Jun-12-20 09:45AM	3 Strong Buy Penny Stocks With Massive Upside Ahead TipRanks +8.25%
Jun-10-20 08:12PM	Do Hedge Funds Love Surface Oncology, Inc. (SURF)? Insider Monkey -5.74%
May-28-20 04:10PM	Surface Oncology Announces Change to Location and Format of 2020 Annual Meeting of Stockholders GlobeNewswire
May-20-20 11:28AM	P/E Ratio Insights for Surface Oncology Benzinga +45.86%
07:15AM	Surface Oncology Fully Utilizes its $30M At-the-Market Facility GlobeNewswire
07:05AM	Surface Oncology and Merck to Collaborate on Immuno-Oncology Study Evaluating SRF617, Targeting CD39 in Combination with KEYTRUDA® (pembrolizumab) in Solid Tumor Patients GlobeNewswire
May-15-20 11:46AM	Upgrade: Analysts Just Made A Massive Increase To Their Surface Oncology, Inc. (NASDAQ:SURF) Forecasts Simply Wall St.
07:30AM	Surface Oncology to Present Preclinical Data for Multiple Product Programs at the American Association for Cancer Research Annual Meeting GlobeNewswire
May-14-20 07:30AM	Surface Oncology to Present at the American Society of Clinical Oncology Annual Meeting GlobeNewswire
May-13-20 08:00AM	Surface Oncology to Present at the UBS Virtual Global Healthcare Conference GlobeNewswire
May-12-20 06:20AM	Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2020 GlobeNewswire -6.41%
May-07-20 12:30PM	Surface Oncology Inc (SURF) to Report Q1 Results: Wall Street Expects Earnings Growth Zacks -11.94%
Apr-23-20 08:00AM	Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Antibody SRF388 GlobeNewswire
Mar-17-20 08:00AM	Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Candidate SRF617 GlobeNewswire
Mar-12-20 10:39AM	Earnings Beat: Surface Oncology, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts Simply Wall St. -6.33%
Mar-10-20 06:20AM	Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2019 GlobeNewswire +10.08%
Mar-06-20 11:30AM	Is Surface Oncology (SURF) Outperforming Other Medical Stocks This Year? Zacks -8.36%
Feb-25-20 04:05PM	Surface Oncology to Present at the 40th Annual Cowen Healthcare Conference GlobeNewswire -14.43%
Feb-19-20 11:30AM	Is Surface Oncology (SURF) Stock Outpacing Its Medical Peers This Year? Zacks +9.68%
Feb-04-20 06:58AM	Surface Oncology, Inc. (SURF) Shares March Higher, Can It Continue? Zacks
Jan-28-20 07:12AM	The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics Benzinga -8.62%
Jan-27-20 04:05PM	Surface Oncology Announces FDA Clearance of SRF617 and SRF388 INDs to Initiate Phase 1 Clinical Trials GlobeNewswire -5.84%
Dec-23-19 10:24AM	Did Hedge Funds Drop The Ball On Surface Oncology, Inc. (SURF) ? Insider Monkey
Dec-09-19 05:45PM	Notice to Shareholders of Surface Oncology, Inc. (NASDAQ: SURF) Regarding Dismissal of Putative Investor Class Action Business Wire -6.70%
Nov-26-19 11:07AM	Company News For Nov 26, 2019 Zacks +10.87%
08:00AM	Surface Oncology to Present at Evercore ISI 2nd Annual HealthCONx Conference GlobeNewswire
Nov-25-19 08:00AM	Surface Oncology Announces $25 Million Debt Financing from K2 HealthVentures GlobeNewswire -21.03%
Nov-18-19 06:30AM	Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day GlobeNewswire -11.67%
Nov-12-19 07:45AM	Surface Oncology, Inc. (SURF) Reports Q3 Loss, Lags Revenue Estimates Zacks
06:30AM	Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2019 GlobeNewswire
Nov-07-19 08:00AM	Surface Oncology Presents Updates at the Society for Immunotherapy of Cancers Annual Meeting GlobeNewswire
Oct-26-19 06:25PM	Kaskela Law LLC Announces Investigation of Surface Oncology, Inc. on Behalf of Investors - SURF ACCESSWIRE
Oct-07-19 07:00AM	Surface Oncology to Host Analyst and Investor Day on November 18, 2019 in New York City GlobeNewswire
Sep-23-19 12:50PM	Here's Why Surface Oncology (NASDAQ:SURF) Must Use Its Cash Wisely Simply Wall St.
Sep-18-19 05:55PM	IPO INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE -7.32%
Sep-17-19 05:25PM	Lifshitz & Miller LLP Announces Investigation of Curaleaf Holdings, Inc., Granite Construction, Inc., Karyopharm Therapeutics, Inc., ProPetro Holdings Corp., SAExploration, Inc., Sunnova Energy International, Inc., and Surface Oncology, Inc. PR Newswire -8.48%
Sep-03-19 04:05PM	Surface Oncology to Present at the Baird 2019 Global Healthcare Conference GlobeNewswire
01:45PM	IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
07:00AM	Ramy Ibrahim, M.D. to Join Surface Oncology Board of Directors GlobeNewswire
Aug-28-19 10:45AM	ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire +5.56%
Aug-27-19 08:00AM	Bragar Eagel & Squire, P.C. is Investigating Casa Systems, Greenlane Holdings, Surface Oncology, and Sunnova Energy on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
Aug-21-19 08:45PM	IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Aug-20-19 01:15PM	URGENT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Aug-15-19 11:20PM	ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Aug-14-19 08:55PM	Bragar Eagel & Squire, P.C. is Investigating Casa Systems, Greenlane Holdings, Surface Oncology, and Pintec Technology on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
Aug-12-19 06:20PM	IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Aug-08-19 09:05PM	URGENT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Aug-07-19 10:30PM	IMPORTANT INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
09:30PM	Bragar Eagel & Squire, P.C. is Investigating Greenlane Holdings, Surface Oncology, and Pintec Technology on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
10:07AM	ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
09:05AM	Surface Oncology, Inc. (SURF) Reports Q2 Loss, Lags Revenue Estimates Zacks
06:05AM	Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2019 GlobeNewswire
Aug-06-19 05:52PM	Shareholder Alert: Robbins Arroyo LLP is Investigating Surface Oncology, Inc. (SURF) Business Wire
12:55PM	INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
10:30AM	Will Surface Oncology, Inc. (SURF) Report Negative Q2 Earnings? What You Should Know Zacks
Aug-03-19 11:05AM	Shareholder Rights Law Firm Johnson Fistel Launches Investigations PR Newswire
Aug-01-19 01:15PM	INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE +10.41%
Jul-30-19 09:25PM	ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Jul-29-19 01:15PM	IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm ACCESSWIRE
Jul-26-19 11:40PM	INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Jul-25-19 03:09PM	Investors Who Bought Surface Oncology (NASDAQ:SURF) Shares A Year Ago Are Now Down 79% Simply Wall St.
Jun-07-19 12:00PM	Surface Oncology to Participate in 40th Annual Goldman Sachs Global Healthcare Conference GlobeNewswire
May-31-19 01:33PM	Analysts Recommend These 3 Falling Knives GuruFocus.com
May-24-19 06:00AM	Surface Oncology Presents Preclinical Data Further Supporting Anti-Tumor Mechanism of CD73 and CD39 Programs at Brisbane Immunotherapy 2019 GlobeNewswire
May-15-19 04:00PM	Surface Oncology to Present at Two Upcoming Healthcare Conferences GlobeNewswire
May-09-19 10:55AM	Surface Oncology, Inc. (SURF) Reports Q1 Loss, Tops Revenue Estimates Zacks -7.48%
07:00AM	Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2019 GlobeNewswire
Apr-24-19 07:00AM	Surface Oncology Management to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor Day GlobeNewswire
Apr-01-19 07:00AM	Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer GlobeNewswire
Mar-04-19 07:00AM	Surface Oncology to Present at the 39th Annual Cowen Healthcare Conference GlobeNewswire
Feb-21-19 09:01AM	Could Surface Oncology, Inc.s (NASDAQ:SURF) Investor Composition Influence The Stock Price? Simply Wall St. -8.93%
Feb-04-19 04:21PM	Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388 GlobeNewswire
Jan-16-19 04:50PM	Publication in ImmunoHorizons Highlights the Role of IL-27 in Upregulation of Multiple Checkpoint Proteins GlobeNewswire
Jan-10-19 06:00AM	Kill the Cancer Stem Cell, Kill the Cancer: How One Biotech is Hitting Cancer at the Cause ACCESSWIRE
Jan-04-19 07:00AM	Surface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory Board GlobeNewswire +13.00%
Dec-21-18 07:00AM	Surface Oncology Added to the NASDAQ Biotechnology Index GlobeNewswire -8.64%
Dec-18-18 04:01PM	Surface Oncology Resets Portfolio Priorities, Extends Cash Runway Through 2021 GlobeNewswire -5.24%
Dec-17-18 07:00AM	Surface Oncology Promotes Jessica Fees to Senior Vice President, Finance and Business Operations GlobeNewswire -5.21%
Nov-20-18 07:00AM	Surface Oncology Announces Upcoming Investor Presentations GlobeNewswire
Nov-13-18 06:30AM	Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2018 GlobeNewswire
Sep-19-18 03:43PM	Surface Oncology Offers 'Robust Pipeline,' Baird Says In Bullish Initiation Benzinga +10.19%
Aug-30-18 09:59AM	Surface Oncology to Present at the Baird 2018 Global Healthcare Conference GlobeNewswire
Aug-14-18 07:00AM	Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2018 GlobeNewswire
Jul-30-18 02:24PM	FDA Grants Orphan Drug Designation to Surface Oncologys SRF231 for the Treatment of Multiple Myeloma GlobeNewswire
Jul-03-18 06:23AM	Goodwin dominates this years record batch of Mass. biotech IPOs American City Business Journals
Jun-21-18 07:00AM	Surface Oncology Recognized as one of the Best Places to Work by Boston Business Journal GlobeNewswire
Jun-20-18 10:01PM	[$$] Eidos Therapeutics Goes Public, Joining Biotech IPO Flurry The Wall Street Journal

Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies. The company develops human immunoglobulin isotype G4 monoclonal antibodies, including SRF231 inhibiting CD47; NZV930 inhibiting CD73; SRF617 inhibiting CD39; SRF388 targeting interleukin 27; and SRF813 targeting CD112R. It also develops various earlier stage programs that targets other critical components of the tumor microenvironment, including regulatory T cells and natural killer cells. The company has a strategic collaboration agreement with Novartis Institutes for Biomedical Research, Inc. for the development of cancer therapies; and the Merck Sharp & Dohme Corp. to evaluate the safety and efficacy of combining Surface's SRF617, an investigational antibody therapy targeting CD39, with Merck's KEYTRUDA (pembrolizumab), the first anti-PD-1 therapy approved in the United States. Surface Oncology, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROSS ROBERT W.	Chief Medical Officer	Oct 14	Sale	10.05	4,000	40,200	101,000	Oct 16 08:02 PM
EcoR1 Capital, LLC	10% Owner	Sep 01	Sale	7.14	332,780	2,376,681	4,701,081	Sep 03 04:17 PM
New Enterprise Associates 14,	10% Owner	May 20	Sale	3.66	420,000	1,535,562	2,892,877	May 22 04:56 PM
Goater Jeff	Chief Executive Officer	Feb 05	Buy	3.23	5,000	16,150	262,000	Feb 07 04:05 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience